Jia Li

Jia Li

Auto-generated profile, based on publicly available information

Jia Li

Affiliation Department of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in Life Sciences
Verified
Journal Article
Open access
GZGang Zhong
Gang Zhong
HLHuiping Long
Huiping Long
SMShiting Ma
Shiting Ma
YSYao Shunhan
Yao Shunhan
JLJia Li
Jia Li
JYJun Yao
Jun Yao
Osteoarthritis (OA) is a chronic and degenerative joint disease prevalent in the elderly, which is characterized by hypertrophy and reactive hyperplasia of articular cartilage. Autophagy has been reported to inhibit inflammation and reduce chondrocyte apoptosis in OA. As the microRNA (miRNA)-335-5p has been linked to both inflammation and autophagy, this study aimed to investigate its potential role in regulating autophagy during the pathogenesis of OA. Quantitative real-time PCR (qRT-PCR) was used to detect miRNA-335-5p expression in normal and OA human chondrocytes. Following transfection of human OA chondrocytes with double-stranded miRNA-335-5p mimic/inhibitor, qRT-PCR, western blotting, and immunofluorescence were used to determine expression levels of the inflammatory mediators IL-1β, IL-6, and TNF-α, and the autophagic markers Beclin-1, autophagy-related protein 5 (ATG5), and ATG7. The autophagy inhibitor 3-methyladenine (3-MA) was used to link the anti-inflammatory effects of miRNA-335-5p to autophagy. The expression of miRNA-335-5p was significantly lower in OA chondrocytes than in normal chondrocytes. Transfection of human OA chondrocytes with the miRNA-335-5p mimic led to a remarkable increase in viability, a significant increase in autophagy-related factors, and a reduction in inflammatory mediators. Importantly, treatment of miRNA-335-5p-overexpressing OA chondrocytes with the autophagy inhibitor 3-MA restored the expression of inflammatory mediators. We conclude that miRNA-335-5p can significantly alleviate inflammation in human OA chondrocytes by activating autophagy. Therefore, miRNA-335-5p has potential for future use in the clinical diagnosis and treatment of OA.

7 September 2024 in Biomaterials
Verified
Journal Article
Closed access
JMJinzhi Meng
Jinzhi Meng
JLJinfeng Lu
Jinfeng Lu
CJCancai Jiang
Cancai Jiang
LDLingchuan Deng
Lingchuan Deng
MXMeimei Xiao
Meimei Xiao
JLJia Li
Jia Li

1 January 2020 in Life Sciences
Verified
Journal Article
Open access
XZXiaohan Zhang
Xiaohan Zhang
JYJun Yao
Jun Yao
ZWZhengyuan Wu
Zhengyuan Wu
KZKai Zou
Kai Zou
ZYZhenyi Yang
Zhenyi Yang
QWQingjun Wei
Qingjun Wei
Daphnetin (DAP) is a traditional Chinese drug usually used to treat cardiovascular diseases. Studies have confirmed the anti-inflammatory, antioxidant, anti-bacterial and insecticidal, anti-tumor and neuro-protective effects of DAP. However, its anti-arthritic potential remains unexplored. The aim of this study is to investigate the in vitro and in vivo chondroprotective effects of DAP. The effect of DAP on primary rabbit chondrocytes was examined using recombinant human IL-1β for 24 h. For the in vivo studies, rabbits were randomly divided into groups: a normal control group and osteoarthritis (OA) groups. The OA groups received three different doses of DAP for 4 or 8 weeks. The anti-arthritic effect of DAP was assessed using histopathological examinations, qRT-PCR, western blotting and immunohistochemical analysis. Both in vitro and in vivo results indicate that DAP exerts a protective effect against IL-1β in chondrocytes. In vitro, DAP inhibits the expression of IL-6, IL-12, MMP-3, MMP-9 and MMP-13, induced by IL-1β in rabbit chondrocytes, and stimulates the production of IL-10. The inhibitory effect of DAP on the MMPs is partially regulated by the inhibition of the PI3K/AKT, MAPK and NF-κB signaling pathways. The effect of DAP on OA may be attributed to the suppression of inflammatory factor secretion, chondrocyte apoptosis observed by the decrease in pro-apoptotic Caspase-3 and BAX, and the activation of anti-apoptotic BCL-2. DAP has a broad range of prospects in the treatment of OA, which provides a novel therapeutic strategy for OA.

24 April 2019 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
ZWZhengyuan Wu
Zhengyuan Wu
HLHuiping Lu
Huiping Lu
JYJun Yao
Jun Yao
XZXiaohan Zhang
Xiaohan Zhang
YHYimei Huang
Yimei Huang
JZJinmin Zhao
Jinmin Zhao

25 July 2023 in CARTILAGE
Verified
Journal Article
Open access
JLJinfeng Lu
Jinfeng Lu
MYMiao Yu
Miao Yu
JLJia Li
Jia Li
Objective: Protein kinase C-delta (PKC-δ) is involved in apoptosis. This study aimed to establish whether PKC-δ can further promote IL-1β-induced chondrocyte apoptosis by mediating the phosphorylation of the JNK and p38 mitogen-activated protein kinase (MAPK) signaling pathways In osteoarthritis (OA). Methods: We employed chondrocyte staining to determine the extent of cartilage degeneration. PKC-δ and p38 signal expressions were used in the immunohistochemical (IHC) test and apoptosis was assayed at the TUNEL test in human osteoarthritic and controls. We stimulated rat cartilage cells using IL-1β (10 ng/ml)/rottlerin (10 μM) or lentivirus. To determine the apoptosis rate, we employed flow cytometry. The mRNA of both BCL2-related X (BAX) and cysteine aspartate protease 3 (caspase-3) could be measured via qRT-PCR. Western blot measured the protein levels of BAX, caspase-3, PKC-δ, p-JNK/JNK and p-p38/p38. Results: The positive rate of PKC-δ and the apoptotic rate of chondrocytes in OA were higher than controls. The manifestation of PKC-δ was positively related to the degree of cartilage degeneration, p38 protein expression, and apoptosis rate. IL-1β exposure upregulated PKC-δ expression in chondrocytes in a dose-dependent manner. Decreasing PKC-δ expression and its phosphorylation in OA can inhibit MAPK signaling pathway activation (phosphorylation) by downregulating JNK and p38 protein phosphorylation and expression. This inhibition decreases caspase-3 and BAX levels, consequently lowering the apoptosis rate in chondrocytes. Conclusion: PKC-δ activation by IL-1β in OA promotes chondrocyte apoptosis via activation of the JNK and p38 MAPK signal pathways, thereby promoting the OA progression.

6 January 2026 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
YQYue Qiu
Yue Qiu
BYBo Yu
Bo Yu
CJCancai Jiang
Cancai Jiang
HYHuangyi Yin
Huangyi Yin
JMJinzhi Meng
Jinzhi Meng
JYJun Yao
Jun Yao
Osteoarthritis, as one of the major disabling diseases in the elderly, has a long-term impact on patients’ quality of life and brings heavy medical and social burden.